{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T13:05:06Z","timestamp":1745586306858,"version":"3.28.2"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1205.050708","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T19:23:46Z","timestamp":1326137026000},"page":"760-762","source":"Crossref","is-referenced-by-count":4,"title":["Multidrug-resistant Tuberculosis in Military Recruits"],"prefix":"10.3201","volume":"12","author":[{"given":"Grace","family":"Freier","sequence":"first","affiliation":[{"name":"Naval Hospital, Beaufort, South Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Wright","sequence":"additional","affiliation":[{"name":"Naval Hospital, Beaufort, South Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Nelson","sequence":"additional","affiliation":[{"name":"Naval Hospital, Beaufort, South Carolina, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Brenner","sequence":"additional","affiliation":[{"name":"South Carolina Department of Health and Environmental Control, Columbia, SC, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundari","family":"Mase","sequence":"additional","affiliation":[{"name":"California Department of Health, Sacramento, California, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sybil","family":"Tasker","sequence":"additional","affiliation":[{"name":"National Naval Medical Center, Bethesda, Maryland, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Navy Environmental and Preventive Medicine Unit-2, Norfolk, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce K.","family":"Bohnker","sequence":"additional","affiliation":[{"name":"Navy Environmental and Preventive Medicine Unit-2, Norfolk, Virginia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2006,5]]},"reference":[{"key":"key-10.3201\/eid1205.050708-201201090500-R1","unstructured":"BUMEDINST. 6224.8 of 14 Sept 1993. [cited 2005 Mar 03]. Available from http:\/\/navymedicine.med.navy.mil\/Files\/Media\/directives\/6224-8%20ch-1.pdf"},{"key":"key-10.3201\/eid1205.050708-201201090500-R2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic standards and classification of tuberculosis in adults and children.","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid1205.050708-201201090500-R3","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection.","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1205.050708-201201090500-R4","first-page":"59","article-title":"Management of persons exposed to multidrug-resistant tuberculosis.","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1205.050708-201201090500-R5","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.","volume":"167","author":"Papastavros","year":"2002","journal-title":"CMAJ"},{"key":"key-10.3201\/eid1205.050708-201201090500-R6","first-page":"1","article-title":"CDC; Infectious Diseases Society of America. Treatment of tuberculosis.","volume":"52","author":"American Thoracic Society","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1205.050708-201201090500-R7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1378\/chest.106.2.431","article-title":"Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey.","volume":"106","author":"Passannante","year":"1994","journal-title":"Chest"},{"key":"key-10.3201\/eid1205.050708-201201090500-R8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1056\/NEJM199404283301718","article-title":"Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis.","volume":"330","author":"Horn","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1205.050708-201201090500-R9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/clinids\/24.6.1264","article-title":"Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.","volume":"24","author":"Ridzon","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1205.050708-201201090500-R10","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1001\/jama.293.22.2776","article-title":"Update on the treatment of tuberculosis and latent tuberculosis.","volume":"293","author":"Blumberg","year":"2005","journal-title":"JAMA"},{"key":"key-10.3201\/eid1205.050708-201201090500-R11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/AAC.46.4.1022-1025.2002","article-title":"In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.","volume":"46","author":"Alvirez-Freites","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1205.050708-201201090500-R12","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with anti-mycobacterial drug activity.","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1205.050708-201201090500-R13","unstructured":"Gamble-Lawson C, Bowman C, Suesz W, Riegodedios A, Bohnker BK. Tuberculosis in the US Navy and Marine Corps: a 4 year retrospective analysis (2000\u20132003). Navy Medical Surveillance Report. 2004. [cited 2005 Nov 7]. Available from http:\/\/www-nehc.med.navy.mil\/downloads\/prevmed\/NMSROctDec04.pdf"},{"key":"key-10.3201\/eid1205.050708-201201090500-R14","first-page":"1","article-title":"Centers for Disease Control and Prevention; Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.","volume":"54","author":"Taylor","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1205.050708-201201090500-R15","first-page":"1","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC.","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/12\/5\/05-0708_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:12:01Z","timestamp":1732630321000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/12\/5\/05-0708_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,5]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1205.050708","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}